Seoulin Bioscience Co.,Ltd. (KOSDAQ: 038070)
South Korea
· Delayed Price · Currency is KRW
7,300.00
-50.00 (-0.68%)
Oct 11, 2024, 9:00 AM KST
Seoulin Bioscience Co.,Ltd. Revenue
Seoulin Bioscience Co.,Ltd. had revenue of 19.79B KRW in the quarter ending June 30, 2024, a decrease of -6.19%. This brings the company's revenue in the last twelve months to 84.51B, down -2.34% year-over-year. In the year 2023, Seoulin Bioscience Co.,Ltd. had annual revenue of 89.57B, down -14.46%.
Revenue (ttm)
84.51B
Revenue Growth
-2.34%
P/S Ratio
0.73
Revenue / Employee
812.64M
Employees
104
Market Cap
61.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 89.57B | -15.14B | -14.46% |
Dec 31, 2022 | 104.71B | 24.17B | 30.01% |
Dec 31, 2021 | 80.54B | 15.45B | 23.74% |
Dec 31, 2020 | 65.09B | 10.68B | 19.62% |
Dec 31, 2019 | 54.41B | 4.53B | 9.09% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition